UA91960C2 - Liquid pharmaceutical formulations of fsh and lh - Google Patents
Liquid pharmaceutical formulations of fsh and lhInfo
- Publication number
- UA91960C2 UA91960C2 UAA200509209A UA2005009209A UA91960C2 UA 91960 C2 UA91960 C2 UA 91960C2 UA A200509209 A UAA200509209 A UA A200509209A UA 2005009209 A UA2005009209 A UA 2005009209A UA 91960 C2 UA91960 C2 UA 91960C2
- Authority
- UA
- Ukraine
- Prior art keywords
- fsh
- pharmaceutical formulations
- pluronic
- liquid pharmaceutical
- formulations
- Prior art date
Links
Abstract
The invention relates to the field of pharmaceutical formulations of follicle -stimulating hormone (FSH), luteinising hormone (LH), and mixtures of FSH and luteinising hormone (LH), and to methods of producing such formulations. The invention provides a liquid or freeze-dried formulation of FSH, or LH, or FSH and LH comprising a surfactant selected from Pluronic ® F77, Pluronic F87, Pluronic F88 and Pluronic F68.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP03100882 | 2003-04-02 |
Publications (1)
Publication Number | Publication Date |
---|---|
UA91960C2 true UA91960C2 (en) | 2010-09-27 |
Family
ID=36806115
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UAA200509209A UA91960C2 (en) | 2003-04-02 | 2004-04-02 | Liquid pharmaceutical formulations of fsh and lh |
Country Status (4)
Country | Link |
---|---|
CN (1) | CN100488566C (en) |
ES (1) | ES2358330T5 (en) |
UA (1) | UA91960C2 (en) |
ZA (1) | ZA200507287B (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102309745B (en) * | 2008-09-17 | 2013-05-08 | 上海天伟生物制药有限公司 | Glycoprotein composition which almost does not contain subunit |
CN101347613B (en) * | 2008-09-17 | 2011-10-26 | 上海天伟生物制药有限公司 | Composition of glucoprotein containing nearly no subunit and preparation method thereof |
WO2010052879A1 (en) * | 2008-11-04 | 2010-05-14 | あすか製薬株式会社 | Aqueous composition containing follicle-stimulating hormone |
CN102293756A (en) * | 2011-08-24 | 2011-12-28 | 蚌埠丰原涂山制药有限公司 | Freeze-dried powder injection of menotropins and preparation method thereof |
CN104856951A (en) * | 2015-05-06 | 2015-08-26 | 华侨大学 | Follicle stimulating hormone transdermal nanometer emulsion and preparation method thereof |
CN111686079A (en) * | 2019-11-28 | 2020-09-22 | 成都泽研生物技术有限公司 | Follicle stimulating hormone freeze-dried preparation and preparation method and application thereof |
CN115429751B (en) * | 2022-09-21 | 2023-11-17 | 景泽生物医药(合肥)股份有限公司 | Human recombinant follicle-stimulating hormone injection and preparation method thereof |
-
2004
- 2004-04-02 CN CNB2004800145043A patent/CN100488566C/en active Active
- 2004-04-02 ES ES04725385.1T patent/ES2358330T5/en active Active
- 2004-04-02 ZA ZA200507287A patent/ZA200507287B/en unknown
- 2004-04-02 UA UAA200509209A patent/UA91960C2/en unknown
Also Published As
Publication number | Publication date |
---|---|
ES2358330T5 (en) | 2018-12-03 |
ZA200507287B (en) | 2007-03-28 |
CN100488566C (en) | 2009-05-20 |
CN1795012A (en) | 2006-06-28 |
ES2358330T3 (en) | 2011-05-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RS20050737A (en) | Liquid pharmaceutical formulations fish and lh together with a non- ionic surfactant | |
WO2004026231A3 (en) | Formulation for lipophilic agents | |
GB0100758D0 (en) | Immunogenic complex method of preparation thereof and pharmaceutical compositions containing the same, useful for disease control | |
MXPA04001524A (en) | Rapamycin 29-enols. | |
WO2002070438A3 (en) | Compositions for delivering bisphosphonates | |
WO2003002136A3 (en) | Stable formulation of modified glp-1 | |
MXPA04001523A (en) | Rapamycin dialdehydes. | |
WO2006055511A3 (en) | Stable tablet formulation of tetrahydrobiopterin | |
WO2003026487A3 (en) | Medical retrieval device | |
MXPA03006775A (en) | Pharmaceutical formulation. | |
AU2001235006A1 (en) | Prophylactic and therapeutic monoclonal antibodies | |
WO2002085311A3 (en) | Hcg formulation | |
UA91960C2 (en) | Liquid pharmaceutical formulations of fsh and lh | |
WO2005007117A3 (en) | Pharmaceutical formulation and method for treating acid-caused gastrointestinal disorders | |
AU2003255820A1 (en) | Derivatives of 3-hydroxy-4-(cyclyl-alkylaminoalkyl)-5-phenyl-1h-pyrazole as antagonists of the gonadotropin releasing hormone (gnrh) for use in the treatment of sex hormone related conditions, such as prostatic of uterine cancer | |
MXPA03007635A (en) | P-thienylbenzyl-amides serving as agonists of angiotensin-(1-7)-receptors, method for the production thereof, their use and pharmaceutical preparations containing the same. | |
CA2453646A1 (en) | 5-cnac as oral delivery agent for parathyroid hormone fragments | |
WO2004066983A3 (en) | Controlled release of highly soluble agents | |
HK1067865A1 (en) | Use of hcg and lh in controlled ovarian hyperstimulation | |
MY144814A (en) | Liquid pharmaceutical formulations of fsh and lh together with a non-ionic surfactant | |
AU2003267551A1 (en) | Thieno-pyrrole compounds as antagonists of gonadotropin releasing hormone | |
HK1065305A1 (en) | Substituted 4-aminocyclohexanol derivatives | |
TH112701B (en) | FSH and LH pharmaceutical formulations. | |
IL149899A0 (en) | MODIFIED RELEASE PHARMACEUTICAL COMPOSITION CONTAINING BUPROPION HCl AS ACTIVE SUBSTANCE | |
WO2007054151A3 (en) | Use of chorionic gonadotropin as an immunosuppressor |